XML 62 R46.htm IDEA: XBRL DOCUMENT v3.25.0.1
STOCKHOLDERS' EQUITY (Tables)
 12 Months Ended
Dec. 31, 2024
Equity [Abstract]  
Schedule of business acquisitions, by acquisition Stock issuances in relation to acquisitions during the years ended December 31, 2024, 2023, and 2022 were as follows:
(In thousands, except for per share data)
Period of AcquisitionShares IssuedFair Value of Shares Issued
OmicEraMay 2022265,186$14,792 
The acquisition date fair value of the consideration transferred for Resolution Bioscience was approximately $54.2 million, which consisted of the following:
(In thousands)
Cash$52,527 
Fair value of replaced equity awards1,675 
Total purchase price$54,202 
The acquisition date fair value of the consideration transferred for OmicEra was approximately $19.4 million, which consisted of the following:
(In thousands)
Common stock issued$14,792 
Contingent consideration4,600 
Cash paid related to working capital adjustment16 
Total purchase price$19,408 
Schedule of amounts recognized in accumulated other comprehensive income (loss) (AOCI)
The amount recognized in AOCI for the years ended December 31, 2024, 2023 and 2022 were as follows:
(In thousands)Cumulative Translation Adjustment
Unrealized Gain (Loss) on Securities (1)
AOCI
Balance at January 1, 2022
$23 $(1,466)$(1,443)
Other comprehensive income (loss) before reclassifications
30 (4,049)(4,019)
Amounts reclassified from accumulated other comprehensive income (loss)
— 226 226 
Net current period change in accumulated other comprehensive loss30 (3,823)(3,793)
Balance at December 31, 2022$53 $(5,289)$(5,236)
Other comprehensive income (loss) before reclassifications1,321 1,416 2,737 
Amounts reclassified from accumulated other comprehensive income (loss)
— 3,927 3,927 
Net current period change in accumulated other comprehensive loss1,321 5,343 6,664 
Balance at December 31, 2023$1,374 $54 $1,428 
Other comprehensive income (loss) before reclassifications(3,294)873 (2,421)
Amounts reclassified from accumulated other comprehensive income (loss)
— 49 49 
Net current period change in accumulated other comprehensive income (loss)
(3,294)922 (2,372)
Balance at December 31, 2024$(1,920)$976 $(944)
_________________________________
(1)There was no tax impact from the amounts recognized in AOCI for the years ended December 31, 2024, 2023, and 2022. The unrealized gain (loss) recorded on available-for-sale securities is a non-cash investing activity.
Schedule of amounts reclassified from accumulated other comprehensive income (loss)
Amounts reclassified from AOCI for the years ended December 31, 2024, 2023, and 2022 were as follows:
Year Ended December 31,
Details about AOCI Components (In thousands)Affected Line Item in the
Statements of Operations		202420232022
Change in value of available-for-sale investments
Sales and maturities of available-for-sale investments
Investment income (loss)
$49 $3,927 $226 
Total reclassifications$49 $3,927 $226